168 related articles for article (PubMed ID: 37393986)
1. Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors.
Padmanabhan P; Dixit NM
J Theor Biol; 2023 Sep; 572():111568. PubMed ID: 37393986
[TBL] [Abstract][Full Text] [Related]
2. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.
Padmanabhan P; Desikan R; Dixit NM
PLoS Comput Biol; 2020 Dec; 16(12):e1008461. PubMed ID: 33290397
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
Mykytyn AZ; Breugem TI; Geurts MH; Beumer J; Schipper D; van Acker R; van den Doel PB; van Royen ME; Zhang J; Clevers H; Haagmans BL; Lamers MM
J Virol; 2023 Aug; 97(8):e0085123. PubMed ID: 37555660
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection.
Metzdorf K; Jacobsen H; Greweling-Pils MC; Hoffmann M; Lüddecke T; Miller F; Melcher L; Kempf AM; Nehlmeier I; Bruder D; Widera M; Ciesek S; Pöhlmann S; Čičin-Šain L
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851486
[TBL] [Abstract][Full Text] [Related]
6. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
[TBL] [Abstract][Full Text] [Related]
7. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways.
Iwata-Yoshikawa N; Kakizaki M; Shiwa-Sudo N; Okura T; Tahara M; Fukushi S; Maeda K; Kawase M; Asanuma H; Tomita Y; Takayama I; Matsuyama S; Shirato K; Suzuki T; Nagata N; Takeda M
Nat Commun; 2022 Oct; 13(1):6100. PubMed ID: 36243815
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
Zhao H; Lu L; Peng Z; Chen LL; Meng X; Zhang C; Ip JD; Chan WM; Chu AW; Chan KH; Jin DY; Chen H; Yuen KY; To KK
Emerg Microbes Infect; 2022 Dec; 11(1):277-283. PubMed ID: 34951565
[TBL] [Abstract][Full Text] [Related]
9. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
[TBL] [Abstract][Full Text] [Related]
10. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L.
Prasad K; AlOmar SY; Almuqri EA; Rudayni HA; Kumar V
PLoS One; 2021; 16(8):e0256141. PubMed ID: 34407143
[TBL] [Abstract][Full Text] [Related]
11. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.
Koch J; Uckeley ZM; Doldan P; Stanifer M; Boulant S; Lozach PY
EMBO J; 2021 Aug; 40(16):e107821. PubMed ID: 34159616
[TBL] [Abstract][Full Text] [Related]
13. Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2.
Li Y; Wang K; Sun H; Wu S; Wang H; Shi Y; Li X; Yan H; Yang G; Wu M; Li Y; Ding X; Si S; Jiang J; Du Y; Li Y; Hong B
Antiviral Res; 2023 Jun; 214():105606. PubMed ID: 37076089
[TBL] [Abstract][Full Text] [Related]
14. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells.
Icho S; Rujas E; Muthuraman K; Tam J; Liang H; Landreth S; Liao M; Falzarano D; Julien JP; Melnyk RA
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0043922. PubMed ID: 35703551
[TBL] [Abstract][Full Text] [Related]
15. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
Shirato K; Kanou K; Kawase M; Matsuyama S
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
[TBL] [Abstract][Full Text] [Related]
16. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
17. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency.
Strobelt R; Broennimann K; Adler J; Shaul Y
Viruses; 2023 May; 15(5):. PubMed ID: 37243215
[TBL] [Abstract][Full Text] [Related]
19. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
[TBL] [Abstract][Full Text] [Related]
20. Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry.
Wang K; Pan Y; Wang D; Yuan Y; Li M; Chen Y; Bi L; Zhang XE
Virol Sin; 2023 Aug; 38(4):595-605. PubMed ID: 37343929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]